Federal data reveals extent of Teva's role in fueling US opioid crisis | The Times of Israel
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva Pharmaceutics USA acquires three buildings for an R&D campus in West Chester - Philadelphia Business Journal
Meet The New Teva: 8% Global Generics Share, 300 ANDAs, 1,500 Launches :: Scrip
Is Teva Pharmaceuticals a Brilliant Contrarian Pick? | The Motley Fool
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
Teva extends global rebrand with tailored marketing messages for caregivers | Fierce Pharma
Teva Pharmaceuticals (@TevaUSA) / Twitter
Should You Buy Teva Pharmaceutical Industries Ltd (TEVA) Stock After it Is Higher By 3.35% in a Week?
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Teva Maintains 2017 Guidance Despite Copaxone Patent Losses; Q4 Tops | Stock News & Stock Market Analysis - IBD
Opioid Manufacturer Teva Pharmaceuticals Reaches $4B Global Settlement | Law.com
Teva settlement prevents Lupin from launching its Austedo generic until 2033 | Fierce Pharma
Sucralfate Market Business Growth in Future Scope 2022-2028 | SRL Pharma, Nitika Chemicals., Teva Pharmaceutical Industries Ltd., Lisapharma S.p.A, Aptalis Pharma US - Digital Journal
The Pionet Group - Internet Solutions, Information Technologies - Teva Pharmaceutical Industries Ltd.
Why You Should Still Buy Teva (NYSE:TEVA) | Seeking Alpha
Narcotics Analgesics Market Growth in Future Scope 2023-2030 | fizer Inc., Teva Pharmaceuticals, Allergan plc, BioDelivery Sciences International - Digital Journal
DEF 14A
Teva Pharmaceutical: 2023 Could Finally Be The Stock's Breakout Year (NYSE: TEVA) | Seeking Alpha
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
Teva Pharmaceuticals: Past, Present, Future | Pharmanewsonline
Teva Pharmaceuticals Near 20-Year Lows (NYSE:TEVA) | Seeking Alpha
Teva to eliminate 14,000 jobs, close facilities, in major restructuring - Philadelphia Business Journal
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
